| 11.66 0.22 (1.92%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 14.77 |
1-year : | 17.25 |
| Resists | First : | 12.64 |
Second : | 14.77 |
| Pivot price | 11.4 |
|||
| Supports | First : | 11.4 |
Second : | 10.63 |
| MAs | MA(5) : | 11.23 |
MA(20) : | 11.43 |
| MA(100) : | 11.64  |
MA(250) : | 13.65 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 39.9 |
D(3) : | 30.3 |
| RSI | RSI(14): 54.5 |
|||
| 52-week | High : | 20.15 | Low : | 9.3 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AVNS ] has closed below upper band by 29.7%. Bollinger Bands are 7.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.7 - 11.74 | 11.74 - 11.78 |
| Low: | 11.34 - 11.39 | 11.39 - 11.44 |
| Close: | 11.58 - 11.65 | 11.65 - 11.72 |
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Thu, 06 Nov 2025
Avanos Medical (AVNS) Q3 2025 Earnings Transcript - The Motley Fool
Thu, 06 Nov 2025
Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View - Yahoo Finance
Thu, 06 Nov 2025
Avanos Medical: Q3 Earnings Snapshot - theheraldreview.com
Thu, 06 Nov 2025
Avanos Medical (AVNS) Net Losses Worsen 74.4% Annually, Undercutting Bullish Value Narratives - Yahoo Finance
Wed, 05 Nov 2025
Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates - sharewise.com
Wed, 05 Nov 2025
Avanos Medical Inc (AVNS) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 46 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 4 (%) |
| Held by Institutions | 92.8 (%) |
| Shares Short | 2,320 (K) |
| Shares Short P.Month | 3,190 (K) |
| EPS | -10.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.76 |
| Profit Margin | -66.9 % |
| Operating Margin | 1.4 % |
| Return on Assets (ttm) | 2.1 % |
| Return on Equity (ttm) | -46.2 % |
| Qtrly Rev. Growth | 1.8 % |
| Gross Profit (p.s.) | 8.03 |
| Sales Per Share | 14.92 |
| EBITDA (p.s.) | 1.9 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 113 (M) |
| Levered Free Cash Flow | 101 (M) |
| PE Ratio | -1.17 |
| PEG Ratio | 0 |
| Price to Book value | 0.69 |
| Price to Sales | 0.78 |
| Price to Cash Flow | 4.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|